Lombard Odier Asset Management (Switzerland) Sa Biogen Inc. Transaction History
Lombard Odier Asset Management (Switzerland) Sa
- $1.93 Billion
- Q2 2025
A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Biogen Inc. stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 16,430 shares of BIIB stock, worth $2.53 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
16,430
Previous 21,052
21.96%
Holding current value
$2.53 Million
Previous $2.88 Million
28.37%
% of portfolio
0.11%
Previous 0.18%
Shares
25 transactions
Others Institutions Holding BIIB
# of Institutions
1,039Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.67 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.44 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.24 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.15 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$740 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...